BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mulier S, Ni Y, Jamart J, Michel L, Marchal G, Ruers T. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann Surg Oncol. 2008;15:144-157. [PMID: 17906898 DOI: 10.1245/s10434-007-9478-5] [Cited by in Crossref: 98] [Cited by in F6Publishing: 80] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 de Meijer VE, Ijzermans JN, Verhoef C. A place for radiofrequency ablation in the treatment of resectable colorectal liver metastases? Ann Surg Oncol 2008;15:2063; author reply 2064-5. [PMID: 18327529 DOI: 10.1245/s10434-008-9843-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
2 Ahmed S, Bathe O, Berry S, Buie D, Davies J, Doll C, Dowden S, Gill S, Gordon V, Hebbard P, Jones E, Kennecke H, Koski S, Krahn M, Le D, Lim H, Lund C, Luo Y, Mcffadden A, Mcghie J, Mulder K, Park J, Rashidi F, Sami A, Tan KT, Wong R. Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5-6, 2014. Curr Oncol 2015;22:e113-23. [PMID: 25908916 DOI: 10.3747/co.22.2362] [Reference Citation Analysis]
3 Seror O. Percutaneous hepatic ablation: What needs to be known in 2014. Diagnostic and Interventional Imaging 2014;95:665-75. [DOI: 10.1016/j.diii.2014.04.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
4 van der Pool AE, Lalmahomed ZS, de Wilt JH, Eggermont AM, Ijzermans JM, Verhoef C. Local treatment for recurrent colorectal hepatic metastases after partial hepatectomy. J Gastrointest Surg 2009;13:890-5. [PMID: 19132450 DOI: 10.1007/s11605-008-0794-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
5 Helmberger T. [Interventional procedures for hepatic metastases]. Chirurg. 2010;81:542-550. [PMID: 20502849 DOI: 10.1007/s00104-010-1888-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
6 de Jong MC, van Vledder MG, Ribero D, Hubert C, Gigot JF, Choti MA, Schulick RD, Capussotti L, Dejong CH, Pawlik TM. Therapeutic efficacy of combined intraoperative ablation and resection for colorectal liver metastases: an international, multi-institutional analysis. J Gastrointest Surg 2011;15:336-44. [PMID: 21108017 DOI: 10.1007/s11605-010-1391-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
7 Weng M, Zhang Y, Zhou D, Yang Y, Tang Z, Zhao M, Quan Z, Gong W. Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis. PLoS One. 2012;7:e45493. [PMID: 23029051 DOI: 10.1371/journal.pone.0045493] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 5.1] [Reference Citation Analysis]
8 Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, Chen MH, Choi BI, de Baère T, Dodd GD. Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. J Vasc Interv Radiol. 2014;25:1691-705.e4. [PMID: 25442132 DOI: 10.1016/j.jvir.2014.08.027] [Cited by in Crossref: 253] [Cited by in F6Publishing: 243] [Article Influence: 31.6] [Reference Citation Analysis]
9 Rempp H, Boss A, Helmberger T, Pereira P. The current role of minimally invasive therapies in the management of liver tumors. Abdom Imaging. 2011;36:635-647. [PMID: 21562884 DOI: 10.1007/s00261-011-9749-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
10 Lee BC, Lee HG, Park IJ, Kim SY, Kim KH, Lee JH, Kim CW, Lee JL, Yoon YS, Lim SB, Yu CS, Kim JC. The role of radiofrequency ablation for treatment of metachronous isolated hepatic metastasis from colorectal cancer. Medicine (Baltimore) 2016;95:e4999. [PMID: 27684857 DOI: 10.1097/MD.0000000000004999] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
11 Kröger T, Pätz T, Altrogge I, Schenk A, Lehmann KS, Frericks BB, Ritz JP, Peitgen HO, Preusser T. Fast Estimation of the Vascular Cooling in RFA Based on Numerical Simulation. Open Biomed Eng J 2010;4:16-26. [PMID: 20448794 DOI: 10.2174/1874120701004020016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
12 Eisele RM, Neumann U, Neuhaus P, Schumacher G. Open surgical is superior to percutaneous access for radiofrequency ablation of hepatic metastases. World J Surg. 2009;33:804-811. [PMID: 19184639 DOI: 10.1007/s00268-008-9905-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
13 Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, Chen MH, Choi BI, de Baère T, Dodd GD, Dupuy DE, Gervais DA, Gianfelice D, Gillams AR, Lee FT, Leen E, Lencioni R, Littrup PJ, Livraghi T, Lu DS, McGahan JP, Meloni MF, Nikolic B, Pereira PL, Liang P, Rhim H, Rose SC, Salem R, Sofocleous CT, Solomon SB, Soulen MC, Tanaka M, Vogl TJ, Wood BJ, Goldberg SN; International Working Group on Image-guided Tumor Ablation; Interventional Oncology Sans Fronti res Expert Panel; Technology Assessment Committee of the Society of Interventional Radiology,; Standard of Practice Committee of the Cardiovascular and Inter. Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology. 2014;273:241-260. [PMID: 24927329 DOI: 10.1148/radiol.14132958] [Cited by in Crossref: 485] [Cited by in F6Publishing: 467] [Article Influence: 60.6] [Reference Citation Analysis]
14 Zhang Y, Peng Z, Chen M, Liu F, Huang J, Xu L, Zhang Y, Chen M. Elevated neutrophil to lymphocyte ratio might predict poor prognosis for colorectal liver metastasis after percutaneous radiofrequency ablation. International Journal of Hyperthermia 2012;28:132-40. [DOI: 10.3109/02656736.2011.654374] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
15 Katayose Y, Unno M. Management of liver metastases from colorectal cancer. Clin J Gastroenterol 2010;3:128-35. [PMID: 26190118 DOI: 10.1007/s12328-010-0155-z] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
16 McKay A, Fradette K, Lipschitz J. Long-term outcomes following hepatic resection and radiofrequency ablation of colorectal liver metastases. HPB Surg 2009;2009:346863. [PMID: 20148084 DOI: 10.1155/2009/346863] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
17 den Brok MH, Nierkens S, Wagenaars JA, Ruers TJ, Schrier CC, Rijke EO, Adema GJ. Saponin-based adjuvants create a highly effective anti-tumor vaccine when combined with in situ tumor destruction. Vaccine 2012;30:737-44. [DOI: 10.1016/j.vaccine.2011.11.080] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
18 Cirocchi R, Trastulli S, Boselli C, Montedori A, Cavaliere D, Parisi A, Noya G, Abraha I. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Cochrane Database Syst Rev. 2012;6:CD006317. [PMID: 22696357 DOI: 10.1002/14651858.cd006317.pub3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
19 Rule W, Timmerman R, Tong L, Abdulrahman R, Meyer J, Boike T, Schwarz RE, Weatherall P, Chinsoo Cho L. Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases. Ann Surg Oncol. 2011;18:1081-1087. [PMID: 21046264 DOI: 10.1245/s10434-010-1405-5] [Cited by in Crossref: 141] [Cited by in F6Publishing: 107] [Article Influence: 11.8] [Reference Citation Analysis]
20 Brouquet A, Andreou A, Vauthey JN. The management of solitary colorectal liver metastases. Surgeon 2011;9:265-72. [PMID: 21843821 DOI: 10.1016/j.surge.2010.12.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
21 Doyle MBM, Chapman WC. Radiofrequency Ablation for Resectable Colorectal Hepatic Metastases: Is It Time for a Randomized Controlled Trial? Annals of Surgery 2010;251:804-6. [DOI: 10.1097/sla.0b013e3181dbb1f8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
22 Burdio F, Mulier S, Navarro A, Figueras J, Berjano E, Poves I, Grande L. Influence of approach on outcome in radiofrequency ablation of liver tumors. Surg Oncol 2008;17:295-9. [PMID: 18472417 DOI: 10.1016/j.suronc.2008.03.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
23 Schlögl M, Pak ES, Bansal AD, Schell JO, Ganai S, Kamal AH, Swetz KM, Maguire JM, Perrakis A, Warraich HJ, Jones CA. Top Ten Tips Palliative Care Clinicians Should Know About Prognostication in Critical Illness and Heart, Kidney, and Liver Diseases. J Palliat Med 2021. [PMID: 34283924 DOI: 10.1089/jpm.2021.0330] [Reference Citation Analysis]
24 Alberts SR, Wagman LD. Chemotherapy for colorectal cancer liver metastases. Oncologist. 2008;13:1063-1073. [PMID: 18838438 DOI: 10.1634/theoncologist.2008-0142] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
25 Berber E, Tsinberg M, Tellioglu G, Simpfendorfer CH, Siperstein AE. Resection versus laparoscopic radiofrequency thermal ablation of solitary colorectal liver metastasis. J Gastrointest Surg. 2008;12:1967-1972. [PMID: 18688683 DOI: 10.1007/s11605-008-0622-8] [Cited by in Crossref: 83] [Cited by in F6Publishing: 75] [Article Influence: 5.9] [Reference Citation Analysis]
26 . Current world literature. Curr Opin Ophthalmol 2009;20:333-41. [PMID: 19535964 DOI: 10.1097/ICU.0b013e32832e478f] [Reference Citation Analysis]
27 Petre EN, Sofocleous C. Thermal Ablation in the Management of Colorectal Cancer Patients with Oligometastatic Liver Disease. Visc Med. 2017;33:62-68. [PMID: 28612019 DOI: 10.1159/000454697] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
28 Ringe KI, Wacker F, Raatschen HJ. Is there a need for MRI within 24 hours after CT-guided percutaneous thermoablation of the liver? Acta Radiol 2015;56:10-7. [PMID: 24445091 DOI: 10.1177/0284185114520858] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
29 Gurusamy KS, Ramamoorthy R, Imber C, Davidson BR. Surgical resection versus non-surgical treatment for hepatic node positive patients with colorectal liver metastases. Cochrane Database Syst Rev 2010;:CD006797. [PMID: 20091607 DOI: 10.1002/14651858.CD006797.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
30 Hompes D, Prevoo W, Ruers T. Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin. Cancer Imaging 2011;11:23-30. [PMID: 21435988 DOI: 10.1102/1470-7330.2011.0004] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
31 Abdel-Misih SR, Schmidt CR, Bloomston PM. Update and review of the multidisciplinary management of stage IV colorectal cancer with liver metastases. World J Surg Oncol 2009;7:72. [PMID: 19788748 DOI: 10.1186/1477-7819-7-72] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
32 Petre EN, Sofocleous CT, Solomon SB. Ablative and catheter-directed therapies for colorectal liver and lung metastases. Hematol Oncol Clin North Am 2015;29:117-33. [PMID: 25475575 DOI: 10.1016/j.hoc.2014.09.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
33 Schiffman SC, Bower M, Brown RE, Martin RC, McMasters KM, Scoggins CR. Hepatectomy is superior to thermal ablation for patients with a solitary colorectal liver metastasis. J Gastrointest Surg. 2010;14:1881-1886; discussion 1886-1887. [PMID: 20859701 DOI: 10.1007/s11605-010-1339-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
34 Wu YZ, Li B, Wang T, Wang SJ, Zhou YM. Radiofrequency ablation vs hepatic resection for solitary colorectal liver metastasis: A meta-analysis. World J Gastroenterol 2011; 17(36): 4143-4148 [PMID: 22039331 DOI: 10.3748/wjg.v17.i36.4143] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
35 Stang A, Fischbach R, Teichmann W, Bokemeyer C, Braumann D. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer. 2009;45:1748-1756. [PMID: 19356924 DOI: 10.1016/j.ejca.2009.03.012] [Cited by in Crossref: 100] [Cited by in F6Publishing: 84] [Article Influence: 7.7] [Reference Citation Analysis]
36 Sofocleous CT, Sideras P, Petre EN. “How we do it” - a practical approach to hepatic metastases ablation techniques. Tech Vasc Interv Radiol. 2013;16:219-229. [PMID: 24238377 DOI: 10.1053/j.tvir.2013.08.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
37 Thaker AA, Razjouyan F, Woods DL, Haemmerich D, Sekhar K, Wood BJ, Dreher MR. Combination therapy of radiofrequency ablation and bevacizumab monitored with power Doppler ultrasound in a murine model of hepatocellular carcinoma. Int J Hyperthermia. 2012;28:766-775. [PMID: 23043501 DOI: 10.3109/02656736.2012.724517] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
38 Rempp H, Waibel L, Hoffmann R, Claussen CD, Pereira PL, Clasen S. MR-guided radiofrequency ablation using a wide-bore 1.5-T MR system: clinical results of 213 treated liver lesions. Eur Radiol 2012;22:1972-82. [DOI: 10.1007/s00330-012-2438-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
39 Rempp H, Loh H, Hoffmann R, Rothgang E, Pan L, Claussen CD, Clasen S. Liver lesion conspicuity during real-time MR-guided radiofrequency applicator placement using spoiled gradient echo and balanced steady-state free precession imaging. J Magn Reson Imaging. 2014;40:432-439. [PMID: 24677447 DOI: 10.1002/jmri.24371] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
40 Guenette JP, Dupuy DE. Radiofrequency ablation of colorectal hepatic metastases. J Surg Oncol. 2010;102:978-987. [PMID: 21166002 DOI: 10.1002/jso.21658] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
41 Polistina F, Costantin G, Febbraro A, Robusto E, Ambrosino G. Aggressive Treatment for Hepatic Metastases from Breast Cancer: Results from a Single Center. World J Surg 2013;37:1322-32. [DOI: 10.1007/s00268-013-1986-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
42 Lehmann KS, Frericks BB, Holmer C, Schenk A, Weihusen A, Knappe V, Zurbuchen U, Peitgen HO, Buhr HJ, Ritz JP. In vivo validation of a therapy planning system for laser-induced thermotherapy (LITT) of liver malignancies. Int J Colorectal Dis 2011;26:799-808. [DOI: 10.1007/s00384-011-1175-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
43 Nijkamp MW, van der Bilt JD, de Bruijn MT, Molenaar IQ, Voest EE, van Diest PJ, Kranenburg O, Borel Rinkes IH. Accelerated perinecrotic outgrowth of colorectal liver metastases following radiofrequency ablation is a hypoxia-driven phenomenon. Ann Surg. 2009;249:814-823. [PMID: 19387320 DOI: 10.1097/sla.0b013e3181a38ef5] [Cited by in Crossref: 63] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
44 Sofocleous CT, Petre EN, Gonen M, Brown KT, Solomon SB, Covey AM, Alago W, Brody LA, Thornton RH, D'Angelica M, Fong Y, Kemeny NE. CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. J Vasc Interv Radiol. 2011;22:755-761. [PMID: 21514841 DOI: 10.1016/j.jvir.2011.01.451] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 6.0] [Reference Citation Analysis]
45 Viallon M, Terraz S, Roland J, Dumont E, Becker CD, Salomir R. Observation and correction of transient cavitation-induced PRFS thermometry artifacts during radiofrequency ablation, using simultaneous Ultrasound/MR imaging: Dynamic susceptibility cavitation artifacts in MRgRFA. Med Phys 2010;37:1491-506. [DOI: 10.1118/1.3309439] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
46 Janne d'Othée B, Sofocleous CT, Hanna N, Lewandowski RJ, Soulen MC, Vauthey JN, Cohen SJ, Venook AP, Johnson MS, Kennedy AS, Murthy R, Geschwind JF, Kee ST. Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol 2012;23:153-63. [PMID: 22264550 DOI: 10.1016/j.jvir.2011.12.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
47 Gameiro SR, Higgins JP, Dreher MR, Woods DL, Reddy G, Wood BJ, Guha C, Hodge JW. Combination therapy with local radiofrequency ablation and systemic vaccine enhances antitumor immunity and mediates local and distal tumor regression. PLoS One. 2013;8:e70417. [PMID: 23894654 DOI: 10.1371/journal.pone.0070417] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 4.4] [Reference Citation Analysis]
48 Rocha FG, D’Angelica M. Treatment of liver colorectal metastases: role of laparoscopy, radiofrequency ablation, and microwave coagulation. J Surg Oncol. 2010;102:968-974. [PMID: 21166000 DOI: 10.1002/jso.21720] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
49 Lehmann KS, Ritz JP, Valdeig S, Knappe V, Schenk A, Weihusen A, Rieder C, Holmer C, Zurbuchen U, Hoffmann P, Peitgen HO, Buhr HJ, Frericks BB. Ex situ quantification of the cooling effect of liver vessels on radiofrequency ablation. Langenbecks Arch Surg 2009;394:475-81. [DOI: 10.1007/s00423-009-0480-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
50 Shan CC, Shi LR, Ding MQ, Zhu YB, Li XD, Xu B, Jiang JT, Wu CP. Cytokine-induced killer cells co-cultured with dendritic cells loaded with the protein lysate produced by radiofrequency ablation induce a specific antitumor response. Oncol Lett 2015;9:1549-56. [PMID: 25788999 DOI: 10.3892/ol.2015.2977] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
51 van Dijk TH, Tamas K, Beukema JC, Beets GL, Gelderblom AJ, de Jong KP, Nagtegaal ID, Rutten HJ, van de Velde CJ, Wiggers T. Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer. Ann Oncol. 2013;24:1762-1769. [PMID: 23524865 DOI: 10.1093/annonc/mdt124] [Cited by in Crossref: 80] [Cited by in F6Publishing: 72] [Article Influence: 8.9] [Reference Citation Analysis]
52 Wong SL, Mangu PB, Choti MA, Crocenzi TS, Dodd GD, Dorfman GS, Eng C, Fong Y, Giusti AF, Lu D, Marsland TA, Michelson R, Poston GJ, Schrag D, Seidenfeld J, Benson AB. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol. 2010;28:493-508. [PMID: 19841322 DOI: 10.1200/jco.2009.23.4450] [Cited by in Crossref: 305] [Cited by in F6Publishing: 123] [Article Influence: 23.5] [Reference Citation Analysis]
53 Kim HR, Cheon SH, Lee KH, Ahn JR, Jeung HC, Lee SS, Chung HC, Noh SH, Rha SY. Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma. Int J Hyperthermia. 2010;26:305-315. [PMID: 20210605 DOI: 10.3109/02656730903555696] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
54 Kron P, Linecker M, Jones RP, Toogood GJ, Clavien PA, Lodge JPA. Ablation or Resection for Colorectal Liver Metastases? A Systematic Review of the Literature. Front Oncol. 2019;9:1052. [PMID: 31750233 DOI: 10.3389/fonc.2019.01052] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
55 Gravante G, Overton J, Sorge R, Bhardwaj N, Metcalfe MS, Lloyd DM, Dennison AR. Radiofrequency ablation versus resection for liver tumours: an evidence-based approach to retrospective comparative studies. J Gastrointest Surg. 2011;15:378-387. [PMID: 21061179 DOI: 10.1007/s11605-010-1377-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
56 Stoffner R, Kremser C, Schullian P, Haidu M, Widmann G, Bale RJ. Multipolar radiofrequency ablation using 4-6 applicators simultaneously: a study in the ex vivo bovine liver. Eur J Radiol 2012;81:2568-75. [PMID: 22297178 DOI: 10.1016/j.ejrad.2011.10.031] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
57 Flanders VL, Gervais DA. Ablation of Liver Metastases: Current Status. Journal of Vascular and Interventional Radiology 2010;21:S214-22. [DOI: 10.1016/j.jvir.2010.01.046] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
58 Nierkens S, den Brok MH, Roelofsen T, Wagenaars JA, Figdor CG, Ruers TJ, Adema GJ. Route of administration of the TLR9 agonist CpG critically determines the efficacy of cancer immunotherapy in mice. PLoS One 2009;4:e8368. [PMID: 20020049 DOI: 10.1371/journal.pone.0008368] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 4.6] [Reference Citation Analysis]
59 Puijk RS, Ruarus AH, Vroomen LGPH, van Tilborg AAJM, Scheffer HJ, Nielsen K, de Jong MC, de Vries JJJ, Zonderhuis BM, Eker HH, Kazemier G, Verheul H, van der Meijs BB, van Dam L, Sorgedrager N, Coupé VMH, van den Tol PMP, Meijerink MR; COLLISION Trial Group. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial. BMC Cancer 2018;18:821. [PMID: 30111304 DOI: 10.1186/s12885-018-4716-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 11.5] [Reference Citation Analysis]
60 Wang LJ, Zhang ZY, Yan XL, Yang W, Yan K, Xing BC. Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis. World J Surg Oncol 2018;16:207. [PMID: 30322402 DOI: 10.1186/s12957-018-1494-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
61 Joo I. The role of intraoperative ultrasonography in the diagnosis and management of focal hepatic lesions. Ultrasonography 2015;34:246-57. [PMID: 25971896 DOI: 10.14366/usg.15014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
62 Topal B, Tiek J, Fieuws S, Aerts R, Van Cutsem E, Roskams T, Prenen H. Minimally invasive liver surgery for metastases from colorectal cancer: oncologic outcome and prognostic factors. Surg Endosc. 2012;26:2288-2298. [PMID: 22311303 DOI: 10.1007/s00464-012-2176-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
63 Preusser T, Peitgen H. Patient-Specific Planning for Radio-Frequency Ablation of Tumors in the Presence of Uncertainty. it - Information Technology 2010;52:265-71. [DOI: 10.1524/itit.2010.0601] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
64 Du H, Tan X, Cheng L, Zhang B, Wang D, Khalaf OI. Application and Evaluation of a 64-Slice CT Three-Dimensional Fusion Technique in the Determination of the Effective Ablation Margin after Radiofrequency Ablation of Hepatocellular Carcinoma. Computational and Mathematical Methods in Medicine 2022;2022:1-12. [DOI: 10.1155/2022/6898233] [Reference Citation Analysis]
65 Gurusamy K, Corrigan N, Croft J, Twiddy M, Morris S, Woodward N, Bandula S, Hochhauser D, Napp V, Pullan A, Jakowiw N, Prasad R, Damink SO, van Laarhoven CJHM, de Wilt JHW, Brown J, Davidson BR. Liver resection surgery versus thermal ablation for colorectal LiVer MetAstases (LAVA): study protocol for a randomised controlled trial. Trials. 2018;19:105. [PMID: 29439711 DOI: 10.1186/s13063-018-2499-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
66 Zhang SJ, Hu P, Wang N, Shen Q, Sun AX, Kuang M, Qian GJ. Thermal ablation versus repeated hepatic resection for recurrent intrahepatic cholangiocarcinoma. Ann Surg Oncol 2013;20:3596-602. [PMID: 23715967 DOI: 10.1245/s10434-013-3035-1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
67 Zurbuchen U, Holmer C, Lehmann KS, Stein T, Roggan A, Seifarth C, Buhr H, Ritz J. Determination of the temperature-dependent electric conductivity of liver tissue ex vivo and in vivo: Importance for therapy planning for the radiofrequency ablation of liver tumours. International Journal of Hyperthermia 2010;26:26-33. [DOI: 10.3109/02656730903436442] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
68 Padma S, Martinie JB, Iannitti DA. Liver tumor ablation: Percutaneous and open approaches. J Surg Oncol. 2009;100:619-634. [PMID: 20017157 DOI: 10.1002/jso.21364] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 5.7] [Reference Citation Analysis]
69 Solomon SB, Sofocleous CT. The interventional radiologist role in treating liver metastases for colorectal cancer. Am Soc Clin Oncol Educ Book 2012;:202-4. [PMID: 24451734 DOI: 10.14694/EdBook_AM.2012.32.115] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
70 Otto G, Düber C, Hoppe-Lotichius M, König J, Heise M, Pitton MB. Radiofrequency ablation as first-line treatment in patients with early colorectal liver metastases amenable to surgery. Ann Surg. 2010;251:796-803. [PMID: 19858704 DOI: 10.1097/sla.0b013e3181bc9fae] [Cited by in Crossref: 88] [Cited by in F6Publishing: 38] [Article Influence: 7.3] [Reference Citation Analysis]
71 Kim KH, Yoon YS, Yu CS, Kim TW, Kim HJ, Kim PN, Ha HK, Kim JC. Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases. J Korean Surg Soc. 2011;81:25-34. [PMID: 22066097 DOI: 10.4174/jkss.2011.81.1.25] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 7.2] [Reference Citation Analysis]
72 Nijkamp MW, Borren A, Govaert KM, Hoogwater FJ, Molenaar IQ, van Diest PJ, Kranenburg O, Borel Rinkes IH. Radiofrequency ablation of colorectal liver metastases induces an inflammatory response in distant hepatic metastases but not in local accelerated outgrowth. J Surg Oncol 2010;101:551-6. [PMID: 20461760 DOI: 10.1002/jso.21570] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
73 Widmann G, Bodner G, Bale R. Tumour ablation: technical aspects. Cancer Imaging 2009;9 Spec No A:S63-7. [PMID: 19965296 DOI: 10.1102/1470-7330.2009.9026] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
74 Roy S. Focal hydrothermal ablation: preliminary investigation of a new concept. Cardiovasc Intervent Radiol 2013;36:1112-9. [PMID: 23377238 DOI: 10.1007/s00270-013-0562-x] [Reference Citation Analysis]
75 Rusconi C, Rampoldi AG, Ravelli E, Nosari AM, Zilioli VR, Vanzulli A, Morra E. Radiofrequency ablation of hepatic Hodgkin lymphoma. Leuk Lymphoma 2009;50:141-4. [PMID: 19152173 DOI: 10.1080/10428190802524837] [Reference Citation Analysis]
76 Sindram D, Lau KN, Martinie JB, Iannitti DA. Hepatic tumor ablation. Surg Clin North Am. 2010;90:863-876. [PMID: 20637953 DOI: 10.1016/j.suc.2010.04.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
77 Topal H, Tiek J, Aerts R, Topal B. Outcome of laparoscopic major liver resection for colorectal metastases. Surg Endosc. 2012;26:2451-2455. [PMID: 22358126 DOI: 10.1007/s00464-012-2209-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
78 Gueorguiev AL, Mackey R, Kowdley GC, Esquivel J, Cunningham SC. Minimally invasive evaluation and treatment of colorectal liver metastases. Int J Surg Oncol 2011;2011:686030. [PMID: 22312518 DOI: 10.1155/2011/686030] [Reference Citation Analysis]
79 Flood MP, Das AA, Soucisse ML, Kong J, Ramsay RG, Michael M, Loveday BPT, Warrier SK, Heriot AG. Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis. Dis Colon Rectum 2021;64:754-64. [PMID: 33742615 DOI: 10.1097/DCR.0000000000002027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Brouquet A, Vauthey JN, Badgwell BD, Loyer EM, Kaur H, Curley SA, Abdalla EK. Hepatectomy for recurrent colorectal liver metastases after radiofrequency ablation. Br J Surg 2011;98:1003-9. [PMID: 21541936 DOI: 10.1002/bjs.7506] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
81 Rueb GR, Brady WJ, Gilliland CA, Patrie JT, Saad WE, Sabri SS, Park AW, Stone JR, Angle JF. Characterizing Cardiopulmonary Arrest during Interventional Radiology Procedures. Journal of Vascular and Interventional Radiology 2013;24:1774-8. [DOI: 10.1016/j.jvir.2013.07.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
82 Dervenis C, Xynos E, Sotiropoulos G, Gouvas N, Boukovinas I, Agalianos C, Androulakis N, Athanasiadis A, Christodoulou C, Chrysou E, Emmanouilidis C, Georgiou P, Karachaliou N, Katopodi O, Kountourakis P, Kyriazanos I, Makatsoris T, Papakostas P, Papamichael D, Pechlivanides G, Pentheroudakis G, Pilpilidis I, Sgouros J, Tekkis P, Triantopoulou C, Tzardi M, Vassiliou V, Vini L, Xynogalos S, Ziras N, Souglakos J. Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO). Ann Gastroenterol 2016;29:390-416. [PMID: 27708505 DOI: 10.20524/aog.2016.0050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
83 Singla S, Hochwald SN, Kuvshinoff B. Evolving ablative therapies for hepatic malignancy. Biomed Res Int 2014;2014:230174. [PMID: 24877069 DOI: 10.1155/2014/230174] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
84 Kröger T, Pätz T, Altrogge I, Schenk A, Lehmann K, Frericks B, Ritz J, Peitgen H, Preusser T. Fast Estimation of the Vascular Cooling in RFA Based on Numerical Simulation. TOBEJ 2010;4:16-26. [DOI: 10.2174/1874120701004010016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]